US Stock MarketDetailed Quotes

VNRX VolitionRX

Watchlist
  • 0.840
  • +0.030+3.70%
Trading Nov 21 14:25 ET
77.84MMarket Cap-2333P/E (TTM)

About VolitionRX Company

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.

Company Profile

SymbolVNRX
Company NameVolitionRX
Listing DateFeb 6, 2015
Founded1998
CEOMr. Cameron John Reynolds
MarketAMEX
Employees110
Fiscal Year Ends12-31
Address1489 West Warm Springs Road,Suite 110
CityHenderson
ProvinceNevada
CountryUnited States of America
Zip Code89014
Phone1-646-650-1351
Websitehttp://www.volition.com

Company Executives

  • Name
  • Position
  • Salary
  • Cameron John Reynolds
  • Chief Executive Officer, President and Director
  • 772.93K
  • Dr. Salvatore Thomas Butera, D.V.M.
  • Chief Executive Officer, Volition Vet
  • 619.79K
  • Dr. Jasmine Kway
  • Chief Executive Officer, Singapore Volition
  • --
  • Dr. Jacob Micallef
  • Chief Scientific Officer
  • --
  • Dr. Andrew Retter
  • Chief Medical Officer
  • --
  • Louise Batchelor
  • Group Chief Marketing and Communications Officer
  • --
  • Terig Hughes
  • Chief Financial Officer, Principal Accounting Officer and Treasurer
  • --
  • Gael Forterre
  • Chief Commercial Officer
  • --
  • Dr. Gaetan Michel
  • Chief Operating Officer
  • 667.81K
  • Timothy I. Still
  • Chairman of the Board
  • --
  • Dr. Ethel Rubin
  • Independent Director
  • --
  • Mickie Henshall
  • Independent Director
  • 2.22K
  • Guy Archibald Innes
  • Lead Independent Director
  • 61.94K
  • Dr. Alan Colman, B.A.
  • Independent Director
  • 86.00K
  • Kim Nguyen
  • Independent Director
  • 61.94K
  • Dr. Phillip Barnes
  • Independent Director
  • 61.94K
  • Nicholas Plummer
  • Group General Counsel
  • --
  • Rodney Gerard Rootsaert
  • Corporate Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-2.39%